Biomedical Engineering Reference
In-Depth Information
56. Murphy M. Current pharmacogenomic approaches to clinical drug
development. Pharmacogenomics . 2000 May; 1(2):115-123.
57. Foster M, Sharp R, Mulvihill J. Pharmacogenetics, race, and ethnicity:
social identities and individualized medical care. Ther Drug Monit .
2001 Jun; 23(3):232-238.
58. Kernan W, Launer L, Goldstein L. What is the future of stroke prevention?:
Debate: polypill versus personalized risk factor modification. Stroke .
2010 Oct; 41(10 Suppl):S35-S38.
59. Whitebread S, Hamon J, Bojanic D, Urban L. Keynote review: in vitro
safety pharmacology profiling: an essential tool for successful drug
development. Drug Discov Today . 2005 Nov; 10(21):1421-1433.
60. Schoonen W, Westerink W, Horbach G. High-throughput screening for
analysis of in vitro toxicity. EXS . 2009; 99:401-452.
61. Gum R, Hickman D, Fagerland J, Heindel M, Gagne G, Schmidt J, et
al. Analysis of two matrix metalloproteinase inhibitors and their
metabolites for induction of phospholipidosis in rat and human
hepatocytes(1). Biochem Pharmacol . 2001 Dec; 62(12):1661-1673.
62. McMillian M, Grant E, Zhong Z, Parker J, Li L, Zivin R, et al. Nile Red
binding to HepG2 cells: an improved assay for in vitro studies of
hepatosteatosis. In Vitr Mol Toxicol . 2001; 14(3):177-190.
63. Fenech M. In vitro micronucleus technique to predict chemosensitivity.
Methods Mol Med . 2005; 111:3-32.
64. Diaz D, Scott A, Carmichael P, Shi W, Costales C. Evaluation of an
automated in vitro micronucleus assay in CHO-K1 cells. Mutat Res .
2007 Jun; 630(1-2):1-13.
65. Kreuter, J. Nanoparticles, J. Swarbrick, J.C. Boylan, Editors, Encyclopedia
of Pharmaceutical Technology, New York (1994).
66. Singh R, Lillard JJ. Nanoparticle-based targeted drug delivery. Exp Mol
Pathol . 2009 Jun; 86(3):215-223.
67. Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;
354(6348):56-58.
68. Adler-Abramovich L, Aronov D, Beker P, Yevnin M, Stempler S,
Buzhansky L, et al. Self-assembled arrays of peptide nanotubes by
vapour deposition. Nat Nanotechnol . 2009 Dec; 4(12):849-854.
69. Wagner E. Programmed drug delivery: nanosystems for tumor
targeting. Expert Opin Biol Ther . 2007 May; 7(5):587-593.
70. Barratt G. Therapeutic applications of colloidal drug carriers. Pharm
Sci Technolo Today . 2000 May; 3(5):163-171.
71. Gregoriadis G. Targeting of drugs. Nature . 1977 Feb; 265(5593):
407-411.
 
Search WWH ::




Custom Search